New drug shows promise for treating bronchiectasis
Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as a therapy for the chronic lung condition. It may soon become the first-ever FDA-approved treatment for bronchiectasis.
https://www.sciencedaily.com/r....eleases/2025/04/2504
Discover the world at Altruu, The Discovery Engine